Interval iud insertion in parous women: a randomized multicentre comparative trial of the Lippes Loop D, TCu220c and the Copper 7.

Abstract:

:A multicentre randomized clinical trial of the TCu220C, Lippes Loop D and Copper 7 was undertaken in nine WHO Collaborating centres for Clinical Research in Human Reproduction. A total of 984, 992 and 994 devices, respectively, were inserted between 1976 and 1978. The subjects were followed for two years. At this time 18,743, 17,013 and 17,927 woman-months experience had been accumulated with each device, respectively. The Lippes Loop consistently failed to perform as well as the TCu220C regardless of age or parity. The TCu220C had statistically significantly lower pregnancy rates at one and two years of use than either of the other two devices as well as lower expulsion rates. The TCu220C had lower removal rates at one and two years than the Lippes Loop and Copper 7. At one and two years the TCu220C had significantly higher continuation rates than the other two devices. It is concluded that the TCu220C is the device of choice amongst the three devices studied. :A multicenter, randomized, clinical trial of the TCu220C, Lippes Loop D, and Copper 7 was undertaken in 9 World Health Organization Collaborating Centers for Clinical Research in Human Reproduction. A total of 984 TCu220, 992 Lippes Loop D, 994 Copper 7 devices were inserted between 1976-78. The subjects were followed for 2 years. 18,743(TCu220C), 17,013(Lippes Loop D), and 17,927(Copper 7) woman-months experience were accumulated with each device. The TCu220C had statistically significantly lower pregnancy and expulsion rates at 1 and 2 years of use than either of the other 2 devices. Overall the TCu220C had lower removal rates at 1 and 2 years than the Lippes Loop and Copper 7; however, the TCu220C and Copper 7 had higher rates for nonmedical removals than the Lippes Loop D. At 1 and 2 years, the TCu220C had significantly higher continuation rates than the other 2 devices which had similar perforance records. It is concluded that the TCu220C is the device of choice among the 3 devices studied.

journal_name

Contraception

journal_title

Contraception

authors

doi

10.1016/0010-7824(82)90167-6

subject

Has Abstract

pub_date

1982-07-01 00:00:00

pages

1-22

issue

1

eissn

0010-7824

issn

1879-0518

pii

0010-7824(82)90167-6

journal_volume

26

pub_type

临床试验,杂志文章,随机对照试验
  • Pharmacokinetic study of orally administered RU 486 in non-pregnant women.

    abstract::A method based on HPLC was devised for the estimation of RU 486 in blood and utilised to study the pharmacokinetics of a single dose of 50 mg RU 486 administered orally to 12 women on day 7 of the cycle. The dose was rapidly absorbed with peak plasma concentration between 1 and 2 hours. Distribution was also rapid (me...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(89)90052-8

    authors: He CH,Shi YE,Ye ZH,Zhang GG,Jiang NX,Van Look PF,Fotherby K

    更新日期:1989-10-01 00:00:00

  • Preoperative cervical priming by intracervical application of a new sulprostone gel.

    abstract::In a prospective, randomised dose-finding study involving 60 women scheduled for termination of 1st trimester pregnancy, 25 micrograms, 50 micrograms or 100 micrograms of a sulprostone gel with a constant injection volume of 2.5 ml were applied intracervically 6-8 hours before curettage. The gelatinising agent was Plu...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(85)90091-5

    authors: Rath W,Dennemark N,Gödicke HD

    更新日期:1985-03-01 00:00:00

  • Grief after second-trimester termination for fetal anomaly: a qualitative study.

    abstract:OBJECTIVES:We aimed to qualitatively evaluate factors that contribute to and alleviate grief associated with termination of a pregnancy for a fetal anomaly and how that grief changes over time. STUDY DESIGN:We conducted a longitudinal qualitative study of decision satisfaction, grief and coping among women undergoing ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.11.015

    authors: Maguire M,Light A,Kuppermann M,Dalton VK,Steinauer JE,Kerns JL

    更新日期:2015-03-01 00:00:00

  • Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.

    abstract::The objective of this study was to compare cycle control, efficacy and tolerance of an oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel with a preparation containing 30 microg ethinylestradiol combined with 75 microg gestodene. This study involved 342 women and 4104 cycles use in Arg...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(00)00153-0

    authors: Bassol S,Alvarado A,Celis C,Cravioto MC,Peralta O,Montaño R,Novelli J,Albornoz H,Kesseru E,Soares A,Petracco A,Isaia B,Mendes J,Bahamondes L,de Melo NR,Reyes-Marquez R,Albrecht G

    更新日期:2000-09-01 00:00:00

  • Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.

    abstract::Patterns of bleeding and plasma concentrations of levonorgestrel, progesterone, estradiol, LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. The IUD was designed to release 12 microgram/day. All but two of the volunteers ovulated during treatment. The ovulatory ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90127-4

    authors: Nilsson CG,Lähteenmäki P,Luukkainen T

    更新日期:1980-02-01 00:00:00

  • Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.

    abstract::First year results of a randomized study of 1509 users of the Copper T380Ag with a silver core or of an IUD releasing 20 mcg day of levonorgestrel are reported. The cumulative gross pregnancy rate for each device was 0.3 per 100 at one year, with more than 490 women having one year of use with each device. The levonor...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(84)90036-2

    authors: Sivin I,Alvarez F,Diaz J,Diaz S,el Mahgoub S,Coutinho E,Brache V,Diaz MM,Faundes A,Pavez M

    更新日期:1984-11-01 00:00:00

  • TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studies.

    abstract:BACKGROUND:Developing an objective, reliable method to determine semen exposure in cervicovaginal fluids is important for accurately studying the efficacy of vaginal microbicides and contraceptives. Y-chromosome biomarkers offer better stability, sensitivity, and specificity than protein biomarkers. TSPY4 belongs to th...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.11.022

    authors: Jacot TA,Zalenskaya I,Mauck C,Archer DF,Doncel GF

    更新日期:2013-09-01 00:00:00

  • Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine device.

    abstract::Intrauterine devices (IUD) provide effective contraception. The current study evaluates the concentration of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in the intrauterine fluid of postmenopausal women using an intrauterine delivery system releasing progesterone (IDS-P). Intrauterine fluid was ob...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(99)00014-1

    authors: Archer DF,DeSoto KR,Baker JM

    更新日期:1999-03-01 00:00:00

  • Effects of intrauterine contraception on the vaginal microbiota.

    abstract:OBJECTIVES:There have been conflicting reports of altered vaginal microbiota and infection susceptibility associated with contraception use. The objectives of this study were to determine if intrauterine contraception altered the vaginal microbiota and to compare the effects of a copper intrauterine device (Cu-IUD) and...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.05.017

    authors: Bassis CM,Allsworth JE,Wahl HN,Sack DE,Young VB,Bell JD

    更新日期:2017-09-01 00:00:00

  • Emetine ditartrate: a possible lead for emergency contraception.

    abstract::Interception of pregnancy in its initial stage is an attractive and viable approach to contraception. A chemical agent, taken within the first few days of missed menses, intercepts the conception, which is expelled with menstrual flow. The main targets of such agents are the uterus, blastocyst and the growing trophobl...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2003.12.011

    authors: Mehrotra PK,Kitchlu S,Dwivedi A,Agnihotri PK,Srivastava S,Roy R,Bhaduri AP

    更新日期:2004-05-01 00:00:00

  • Measuring decisional certainty among women seeking abortion.

    abstract:OBJECTIVE:Evaluating decisional certainty is an important component of medical care, including preabortion care. However, minimal research has examined how to measure certainty with reliability and validity among women seeking abortion. We examine whether the Decisional Conflict Scale (DCS), a measure widely used in ot...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.contraception.2016.09.008

    authors: Ralph LJ,Foster DG,Kimport K,Turok D,Roberts SCM

    更新日期:2017-03-01 00:00:00

  • Effect of a once weekly oral contraceptive upon gonadotrophin and gonadal steroid levels.

    abstract::A moderately effective oral progestogen contraceptive, R-2323 (13beta-ethyl-17alpha-ethynyl-17-hydroxy-gona-4,9,11-trien,3-one), was administered weekly in doses of 2.5 mg and 5 mg to 5 subjects each for 8 weeks. In 2 of the 10 treatment cycles of 2.5 mg and 4 of the 10 treatment cycles of 5 mg, progesterone levels i...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(74)90071-7

    authors: Tredway DR,Mishell DR Jr

    更新日期:1974-08-01 00:00:00

  • Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.

    abstract::Associations between Depo-Provera (injectable, progesterone-only contraceptive) use and visible disruption of cervical epithelium and cervical ectopy were investigated using data collected as part of a cervical cancer screening study in periurban Cape Town, South Africa. Women were interviewed about their contraceptiv...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(99)00049-9

    authors: Kuhn L,Denny L,Pollack AE,Wright TC

    更新日期:1999-06-01 00:00:00

  • Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

    abstract:CONTEXT:There is concern that a new transdermal contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin increases the risk for venous thromboembolism (VTE) compared to previously marketed oral contraceptives (OCs). OBJECTIVE:Quantitative information was obtained on the risk of nonfatal V...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2006.01.001

    authors: Jick SS,Kaye JA,Russmann S,Jick H

    更新日期:2006-03-01 00:00:00

  • Comparison of surface morphology and composition of intrauterine devices in relation to patient complaints.

    abstract::The morphology and the related composition of T-type intrauterine devices (IUDs) made of gold-plated copper were studied in relation to patient complaints. The removed IUDs were examined without pretreatment by scanning electron microscopy and energy dispersive x-ray spectroscopy. Besides the previously found incrusta...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2004.03.006

    authors: Patai K,Dévényi L,Zelkó R

    更新日期:2004-08-01 00:00:00

  • Blood levels of ethynylestradiol, caffeine, aldosterone and desoxycorticosterone in hypertensive oral contraceptive users.

    abstract::Twenty normotensive and ten hypertensive black women taking oral contraceptive (OC) were studied. Age, body weight, family medical history of hypertension, length of OC use, and type of OC were comparable. At midcycle approximately 10-12 hours following OC intake, blood was drawn and the plasma was used to determine e...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(81)80006-6

    authors: Kaul L,Curry CL,Ahluwalia BS

    更新日期:1981-06-01 00:00:00

  • Evaluation of contraceptive activity of a mineralo-herbal preparation in Sprague-Dawley rats.

    abstract:OBJECTIVE:This study was aimed to evaluate a marketed mineralo-herbal preparation containing plants known to have potent contraceptive activity, or contraindicated for use during pregnancy in folklore/ancient Indian literature and recommended for use as an appetizer and headache, hyperacidity and chronic constipation r...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.05.026

    authors: Srivastava SR,Kesarwani S,Keshri G,Singh MM

    更新日期:2005-12-01 00:00:00

  • Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.

    abstract::Sulprostone was given intramuscularly in two dose schedules of 0.5 mg at 4 hourly intervals for 8 doses and 1.0 mg at 8-hour intervals for 4 doses to 56 women in the 12th-20th week of gestation coming for termination of pregnancy. Forty-nine of them aborted within the 30-hour observation period, giving a success rate ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(82)90028-2

    authors: Ranjan V,Hingorani V,Kinra G,Agarwal N,Pande Y

    更新日期:1982-02-01 00:00:00

  • The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

    abstract:BACKGROUND:Polycystic ovary syndrome (PCOS) is an endocrine disorder associated with metabolic dysfunction and changes in cardiovascular risk markers, and using oral contraceptives (OCs) may exert a further negative effect on these alterations in patients with PCOS. Thus, the primary objective of this study was to asse...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2011.12.011

    authors: Vieira CS,Martins WP,Fernandes JB,Soares GM,dos Reis RM,de Sá MF,Ferriani RA

    更新日期:2012-09-01 00:00:00

  • Contraception technology: past, present and future.

    abstract::Steady progress in contraception research has been achieved over the past 50 years. Hormonal and nonhormonal modern contraceptives have improved women's lives by reducing different health conditions that contributed to considerable morbidity. However, the contraceptives available today are not suitable to all users, a...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2012.08.002

    authors: Sitruk-Ware R,Nath A,Mishell DR Jr

    更新日期:2013-03-01 00:00:00

  • Long-term sequelae of tolnidamine on male reproduction and general body metabolism in rabbits.

    abstract::The long-term effects of tolnidamine on male reproduction and general body metabolism were studied in rabbits (Oryctolagus cuniculus). The study was divided into three groups of 10 animals each. The first group (A) received vehicle alone to serve as controls. The second and third groups (B and C) of animals were admin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(98)00031-6

    authors: Ansari AS,Kumar Y,Srivastava S,Lohiya NK

    更新日期:1998-04-01 00:00:00

  • Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.

    abstract:BACKGROUND:This study analyzes levels of progesterone, estradiol, norethindrone (NET) and ethinyl estradiol (EE) in serum and levels of NET in cervical mucus on the last day of the hormone-free interval (HFI) in users of 24/4 [norethindrone acetate (NETA)/EE-24] vs. 21/7 (NETA/EE-21) regimens. STUDY DESIGN:This was a ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2012.12.006

    authors: Fels H,Steward R,Melamed A,Granat A,Stanczyk FZ,Mishell DR Jr

    更新日期:2013-06-01 00:00:00

  • Safety of mifepristone abortions in clinical use.

    abstract:OBJECTIVES:Extensive data from clinical trials document mifepristone's safety and efficacy for induced abortion, but less information is available about its safety in routine clinical use. METHODS:Data on mifepristone abortion use from the Planned Parenthood Federation of America, the largest provider of mifepristone ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.03.011

    authors: Henderson JT,Hwang AC,Harper CC,Stewart FH

    更新日期:2005-09-01 00:00:00

  • Release of proteolytic enzymes from leucocytes attached to IUDs.

    abstract::The leucocytes adhering to intrauterine devices (IUDs) were predominantly mononuclear phagocytic cells (MPCs) and granulocytes. These cells released elastase and a plasminogen activator in the culture medium. The plasminogen activator was found to be immunologically identical to tissue activator, and the release patte...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(82)90083-x

    authors: Casslén B,Ohlsson K,Lindholm K,Astedt B

    更新日期:1982-08-01 00:00:00

  • Studies on mechanism(s) of antifertility action of gossypol in rat and hamster.

    abstract::This study was undertaken with a view to investigate the possible mechanism(s) of antifertility action of gossypol acetate in rats and hamsters. Adult male rats were treated by gavage with 30 mg/kg/day of gossypol for 7 weeks and adult male hamsters were treated similarly with 20 mg/kg/day gossypol for 8 weeks. The tr...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(89)90066-8

    authors: Srivastava A,Gupta G,Setty BS

    更新日期:1989-03-01 00:00:00

  • Misoprostol as an adjunct to overnight osmotic dilators prior to second trimester dilation and evacuation: A systematic review and meta-analysis.

    abstract:OBJECTIVE:To understand effect of adjunct misoprostol on cervical preparation with overnight osmotic dilators for dilation and evacuation after 16 weeks gestation. METHODS:We searched on-line reference databases using search terms for second trimester, abortion, misoprostol, and dilators. Randomized controlled trials ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.09.005

    authors: Cahill EP,Henkel A,Shaw JG,Shaw KA

    更新日期:2020-02-01 00:00:00

  • Long-term follow-up of women treated with Norplant implants.

    abstract::This report describes the long-term follow-up of 376 women who received NORPLANT implants in the period October 1974 through May 1979. One-hundred-and-ten subjects received replacement implants after variable lengths of use of the first set. The average levonorgestrel plasma levels declined steadily through eight year...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(87)80016-1

    authors: Díaz S,Pavez M,Miranda P,Johansson ED,Croxatto HB

    更新日期:1987-06-01 00:00:00

  • Two randomized controlled trials comparing the Hulka and Filshie Clips for tubal sterilization.

    abstract::To compare the effectiveness and safety of the Filshie Clip System and Hulka Clip System when applied via minilaparotomy and laparoscopy, we conducted 2 multicenter randomized controlled trials of 2126 women (878 in the minilaparotomy study and 1248 in the laparoscopy study) who received either the Filshie or Hulka Cl...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(00)00166-9

    authors: Dominik R,Gates D,Sokal D,Cordero M,Lasso de la Vega J,Remes Ruiz A,Thambu J,Lim D,Louissaint S,Galvez RS,Uribe L,Zighelboim I

    更新日期:2000-10-01 00:00:00

  • Evaluation of the effect of a patient decision aid about vasectomy on the decision-making process: a randomized trial.

    abstract:BACKGROUND:Between 7% and 10% of men who choose vasectomy as a contraceptive method regret their decision. This study evaluates the effect of a patient decision aid (PtDA) designed to help men decide whether or not to have a vasectomy. STUDY DESIGN:Men considering vasectomy were randomized to an experimental group tha...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2010.05.003

    authors: Labrecque M,Paunescu C,Plesu I,Stacey D,Légaré F

    更新日期:2010-12-01 00:00:00

  • Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability.

    abstract:BACKGROUND:In levonorgestrel intrauterine system (LNG-IUS) users, the prevention of sperm penetration through cervical mucus has not been demonstrated. STUDY DESIGN:Subjects were enrolled in an investigator-blinded study to compare quality and sperm penetrability of mid-cycle cervical mucus between LNG-IUS users and h...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2010.06.006

    authors: Lewis RA,Taylor D,Natavio MF,Melamed A,Felix J,Mishell D Jr

    更新日期:2010-12-01 00:00:00